Search Results - "Dinerman, Michael"

Surgical Outcomes in High-risk Prostate Cancer and Salvage Radical Prostatectomy by Avda, Yuval, Modai, Jonathan, Shpunt, Igal, Dinerman, Michael, Shilo, Yaniv, Croock, Roy, Jaber, Morad, Linder, Uri, Leibovici, Dan

“…Patients with high-risk prostate cancer are at higher risk of treatment failure, development of metastatic disease, and mortality. There is no consensus on the…”
Get full text

Images in Emergency Medicine: Diagnosis July 2004 by Dinerman, Michael

Get full text

Images in Emergency Medicine by Dinerman, Michael

Get full text

Prospective phase II study of neoadjuvant therapy with cisplatin, 5-fluorouracil, and bevacizumab for locally advanced resectable esophageal cancer by Idelevich, Efraim, Kashtan, Hanoch, Klein, Yoram, Buevich, Victor, Baruch, Noa Ben, Dinerman, Michael, Tokar, Margarita, Kundel, Yulia, Brenner, Baruch

“…We investigated the efficacy and tolerability of cisplatin and 5-fluorouracil (5-FU) plus bevacizumab as neoadjuvant therapy for patients with locally advanced…”
Get more information

Images in emergency medicine. Nutritional rickets resulting from vitamin D deficiency contributing to hypocalcemic seizures by Dinerman, Michael

Get full text

Phase II study of UFT with leucovorin plus hepatic arterial infusion with irinotecan, 5-fluorouracil and leucovorin for non-resectable liver metastases of colorectal cancer by Idelevich, Efraim, Greif, Franklin, Mavor, Eli, Miller, Rafael, Kashtan, Hanoch, Susmalian, Sergo, Ariche, Arie, Brenner, Baruch, Baruch, Noa Ben, Dinerman, Michael, Shani, Adi

“…Compared with systemic therapy, hepatic arterial infusion (HAI) increases the response to fluoropyrimidines. Thirty-one patients with non-resectable,…”
Get more information

Overall survival with cisplatin and 5-fluorouracil neoadjuvant treatment in patients with esophageal cancer: single-center experience by Idelevich, Efraim, Buyevich, Victor, Machlenkin, Svetlana, Ziv-Sokolovsky, Nadya, Dinerman, Michael, Brenner, Baruch, Kashtan, Hanoch

“…The survival benefit of neoadjuvant chemotherapy in patients undergoing surgery for esophageal cancer is unclear. We retrospectively identified 37 patients…”
Get more information

Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer by Idelevich, Efraim, Karminsky, Natalie, Dinerman, Michael, Katsenelson, Rivka L, Zvi, Nana Ben, Baruch, Noa Ben, Biran, Haim, Man, Sofia, Shani, Adi

“…More than two-thirds of patients with gastric cancer present with metastatic disease and their curative options are limited. This phase II study assessed the…”
Get more information